Evidence map›Paper›PMID 22290947›Full record

ArticleAntimicrobial agents and chemotherapy2012

Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.

Allaaeddin El Salabi, Pardha Saradhi Borra, Mark A Toleman, Ørjan Samuelsen, Timothy R Walsh

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Biomedical reports · 2026
    Review
  3. Carbapenem-ResistantMicroorganisms · 2025
    Review
  4. Highly carbapenem-resistantMicrobiology spectrum · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Genomic characterization ofMicrobial genomics · 2021
    Article
  15. Genes · 2021
    Review
  16. Antimicrobial agents and chemotherapy · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Allaaeddin El SalabiCardiff University, Cardiff, United Kingdom.
Pardha Saradhi Borra
Mark A Toleman
Ørjan Samuelsen
Timothy R Walsh
Cardiff University · GBUiT The Arctic University of Norway · NOUniversity Hospital of North Norway · NOUniversity of Queensland · AU

Funding

Medical Research Council G1100135
6 · The paper itself

Abstract

An Achromobacter xylosoxidans strain from the Tripoli central hospital produced a unique metallo-β-lactamase, designated TMB-1, which is related to DIM-1 (62%) and GIM-1 (51%). bla(TMB-1) was embedded in a class 1 integron and located on the chromosome. The TMB-1 β-lactamase has lower k(cat) values than both DIM-1 and GIM-1 with cephalosporins and carbapenems. The K(m) values were more similar to those of GIM-1 than those of DIM-1, with the overall k(cat)/K(m) values being lower than those for GIM-1 and DIM-1.

Indexed as

Achromobacter denitrificansAmino Acid SequenceAnti-Bacterial Agentsbeta-LactamasesCarbapenemsCephalosporinsChromosomes, BacterialDNA, BacterialGram-Negative Bacterial InfectionsHumansIntegronsKineticsLibyaMicrobial Sensitivity TestsMolecular Sequence DataPseudomonas aeruginosaAnti-Bacterial Agentsbeta-lactamase GIM-1, Pseudomonas aeruginosabeta-LactamasesCarbapenemsCephalosporinsDNA, Bacterial

Identifiers

PMID22290947
PMCPMC3346670
OpenAlexW2109836314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.